IMMU - Immunomedics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.77B
Enterprise Value 32.29B
Trailing P/E N/A
Forward P/E 1-9.52
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)-5,750.08
Price/Book (mrq)15.15
Enterprise Value/Revenue 3-4,745.60
Enterprise Value/EBITDA 6-7.01

Trading Information

Stock Price History

Beta (3Y Monthly) 1.55
52-Week Change 3-44.65%
S&P500 52-Week Change 37.06%
52 Week High 327.33
52 Week Low 311.55
50-Day Moving Average 313.41
200-Day Moving Average 315.46

Share Statistics

Avg Vol (3 month) 32.79M
Avg Vol (10 day) 31.51M
Shares Outstanding 5165.77M
Float 157.83M
% Held by Insiders 17.19%
% Held by Institutions 184.82%
Shares Short (Jun 28, 2019) 436.36M
Short Ratio (Jun 28, 2019) 411.13
Short % of Float (Jun 28, 2019) 424.10%
Short % of Shares Outstanding (Jun 28, 2019) 418.98%
Shares Short (prior month May 31, 2019) 433.01M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Jun 24, 1985

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)68,690.87%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)-482k
Revenue Per Share (ttm)-0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-187.77M
EBITDA -326.4M
Net Income Avi to Common (ttm)-367.13M
Diluted EPS (ttm)-1.88
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)442.68M
Total Cash Per Share (mrq)2.31
Total Debt (mrq)7.37M
Total Debt/Equity (mrq)4.05
Current Ratio (mrq)7.89
Book Value Per Share (mrq)0.95

Cash Flow Statement

Operating Cash Flow (ttm)-283.83M
Levered Free Cash Flow (ttm)N/A